Atsena Therapeutics is a clinical-stage gene therapy company based in Durham, North Carolina, in the Research Triangle, developing first- and best-in-class genetic medicines for inherited retinal diseases with the goal of reversing or preventing blindness. Founded by ocular gene therapy pioneers Shannon Boye and Sanford Boye, the company builds on two proprietary AAV delivery platforms: a laterally spreading AAV.SPR capsid engineered to reach retinal cells without the surgical trauma of a subretinal bleb, and a dual-vector technology that splits genes too large for a single AAV across two vectors. Its clinical pipeline includes ATSN-201 for X-linked retinoschisis (XLRS) in a pivotal Phase 3 trial, ATSN-101 for LCA1 (Leber congenital amaurosis 1) advancing to a pivotal trial with partner Nippon Shinyaku, and IND-enabling programs ATSN-301 for Usher syndrome 1B and ATSN-401 for Stargardt disease. Atsena runs no developer program and publishes no product API, no developer documentation and no specification of its own. The only machine-readable surface it exposes is the anonymously readable WordPress REST content API behind atsenatx.com, which serves the company's press releases, program and platform pages, and media library as JSON; the OpenAPI in this repo is derived by API Evangelist from that surface's own live route index.
Atsena Therapeutics publishes 8 APIs on the APIs.io network, including Categories API, Discovery API, Media API, and 5 more. Tagged areas include Company, Biotechnology, Gene Therapy, Life Sciences, and Pharmaceuticals.
Atsena Therapeutics’ developer surface includes engineering blog, product news, support, authentication, and 27 more developer resources.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: atsena-therapeutics
name: Atsena Therapeutics
description: 'Atsena Therapeutics is a clinical-stage gene therapy company based in Durham, North Carolina, in the Research
Triangle, developing first- and best-in-class genetic medicines for inherited retinal diseases with the goal of reversing
or preventing blindness. Founded by ocular gene therapy pioneers Shannon Boye and Sanford Boye, the company builds on two
proprietary AAV delivery platforms: a laterally spreading AAV.SPR capsid engineered to reach retinal cells without the surgical
trauma of a subretinal bleb, and a dual-vector technology that splits genes too large for a single AAV across two vectors.
Its clinical pipeline includes ATSN-201 for X-linked retinoschisis (XLRS) in a pivotal Phase 3 trial, ATSN-101 for LCA1
(Leber congenital amaurosis 1) advancing to a pivotal trial with partner Nippon Shinyaku, and IND-enabling programs ATSN-301
for Usher syndrome 1B and ATSN-401 for Stargardt disease. Atsena runs no developer program and publishes no product API,
no developer documentation and no specification of its own. The only machine-readable surface it exposes is the anonymously
readable WordPress REST content API behind atsenatx.com, which serves the company''s press releases, program and platform
pages, and media library as JSON; the OpenAPI in this repo is derived by API Evangelist from that surface''s own live route
index.'
url: https://raw.githubusercontent.com/api-evangelist/atsena-therapeutics/refs/heads/main/apis.yml
image: https://atsenatx.com/wp-content/themes/atsenatx/img/touch-icon-ipad-retina.png
x-type: company
x-source: harvest:secondary-market
x-tier: enriched
x-tier-reason: enrichment pass 2026-08-02
specificationVersion: '0.23'
created: '2026-08-02'
modified: '2026-08-02'
tags:
- Company
- Biotechnology
- Gene Therapy
- Life Sciences
- Pharmaceuticals
- Clinical Trials
- Ophthalmology
- Rare Disease
- Healthcare
- Research and Development
- content-api
- WordPress
tags_raw:
- Company
- Biotechnology
- Gene Therapy
- Life Sciences
- Pharmaceuticals
- Clinical Trials
- Ophthalmology
- Rare Disease
- Healthcare
- Research and Development
- Content API
- WordPress
apis:
- aid: atsena-therapeutics:atsena-therapeutics-categories-api
name: Atsena Therapeutics Categories API
description: Post categories
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://atsenatx.com/wp-json
tags:
- Categories
properties:
- type: OpenAPI
url: openapi/atsena-therapeutics-categories-api-openapi.yml
- type: Authentication
url: authentication/atsena-therapeutics-authentication.yml
- type: Conventions
url: conventions/atsena-therapeutics-conventions.yml
- type: ErrorCatalog
url: errors/atsena-therapeutics-problem-types.yml
- type: DataModel
url: data-model/atsena-therapeutics-data-model.yml
- aid: atsena-therapeutics:atsena-therapeutics-discovery-api
name: Atsena Therapeutics Discovery API
description: Route index, content types, taxonomies and post statuses
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://atsenatx.com/wp-json
tags:
- Discovery
properties:
- type: OpenAPI
url: openapi/atsena-therapeutics-discovery-api-openapi.yml
- type: Authentication
url: authentication/atsena-therapeutics-authentication.yml
- type: Conventions
url: conventions/atsena-therapeutics-conventions.yml
- type: ErrorCatalog
url: errors/atsena-therapeutics-problem-types.yml
- type: DataModel
url: data-model/atsena-therapeutics-data-model.yml
- aid: atsena-therapeutics:atsena-therapeutics-media-api
name: Atsena Therapeutics Media API
description: Media library items
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://atsenatx.com/wp-json
tags:
- Media
properties:
- type: OpenAPI
url: openapi/atsena-therapeutics-media-api-openapi.yml
- type: Authentication
url: authentication/atsena-therapeutics-authentication.yml
- type: Conventions
url: conventions/atsena-therapeutics-conventions.yml
- type: ErrorCatalog
url: errors/atsena-therapeutics-problem-types.yml
- type: DataModel
url: data-model/atsena-therapeutics-data-model.yml
- aid: atsena-therapeutics:atsena-therapeutics-oembed-api
name: Atsena Therapeutics O Embed API
description: oEmbed representation of site URLs
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://atsenatx.com/wp-json
tags:
- oEmbed
properties:
- type: OpenAPI
url: openapi/atsena-therapeutics-oembed-api-openapi.yml
- type: Authentication
url: authentication/atsena-therapeutics-authentication.yml
- type: Conventions
url: conventions/atsena-therapeutics-conventions.yml
- type: ErrorCatalog
url: errors/atsena-therapeutics-problem-types.yml
- type: DataModel
url: data-model/atsena-therapeutics-data-model.yml
- aid: atsena-therapeutics:atsena-therapeutics-pages-api
name: Atsena Therapeutics Pages API
description: 'Static site pages: programs, technology, clinical trials, patients, about'
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://atsenatx.com/wp-json
tags:
- Pages
properties:
- type: OpenAPI
url: openapi/atsena-therapeutics-pages-api-openapi.yml
- type: Authentication
url: authentication/atsena-therapeutics-authentication.yml
- type: Conventions
url: conventions/atsena-therapeutics-conventions.yml
- type: ErrorCatalog
url: errors/atsena-therapeutics-problem-types.yml
- type: DataModel
url: data-model/atsena-therapeutics-data-model.yml
- aid: atsena-therapeutics:atsena-therapeutics-posts-api
name: Atsena Therapeutics Posts API
description: Press releases and company news
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://atsenatx.com/wp-json
tags:
- Posts
properties:
- type: OpenAPI
url: openapi/atsena-therapeutics-posts-api-openapi.yml
- type: Authentication
url: authentication/atsena-therapeutics-authentication.yml
- type: Conventions
url: conventions/atsena-therapeutics-conventions.yml
- type: ErrorCatalog
url: errors/atsena-therapeutics-problem-types.yml
- type: DataModel
url: data-model/atsena-therapeutics-data-model.yml
- aid: atsena-therapeutics:atsena-therapeutics-search-api
name: Atsena Therapeutics Search API
description: Cross-content search over posts and pages
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://atsenatx.com/wp-json
tags:
- Search
properties:
- type: OpenAPI
url: openapi/atsena-therapeutics-search-api-openapi.yml
- type: Authentication
url: authentication/atsena-therapeutics-authentication.yml
- type: Conventions
url: conventions/atsena-therapeutics-conventions.yml
- type: ErrorCatalog
url: errors/atsena-therapeutics-problem-types.yml
- type: DataModel
url: data-model/atsena-therapeutics-data-model.yml
- aid: atsena-therapeutics:atsena-therapeutics-tags-api
name: Atsena Therapeutics Tags API
description: Post tags
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://atsenatx.com/wp-json
tags:
- Tags
properties:
- type: OpenAPI
url: openapi/atsena-therapeutics-tags-api-openapi.yml
- type: Authentication
url: authentication/atsena-therapeutics-authentication.yml
- type: Conventions
url: conventions/atsena-therapeutics-conventions.yml
- type: ErrorCatalog
url: errors/atsena-therapeutics-problem-types.yml
- type: DataModel
url: data-model/atsena-therapeutics-data-model.yml
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Website
url: https://atsenatx.com/
- type: About
url: https://atsenatx.com/about/overview/
- type: Blog
url: https://atsenatx.com/news/
- type: News
url: https://atsenatx.com/news/
- type: PressReleases
url: https://atsenatx.com/news/press-releases/
- type: BlogRSS
url: https://atsenatx.com/feed/
- type: Publications
url: https://atsenatx.com/news/presentations-and-publications/
- type: Pipeline
url: https://atsenatx.com/programs/pipeline/
- type: Technology
url: https://atsenatx.com/our-approach/
- type: ClinicalTrials
url: https://atsenatx.com/clinical-trials/
- type: Patients
url: https://atsenatx.com/for-patients/
- type: PrivacyPolicy
url: https://atsenatx.com/privacy-policy/
- type: Support
url: https://atsenatx.com/contact/
- type: Contact
url: https://atsenatx.com/contact/
- type: Careers
url: https://atsenatx.com/careers/
- type: LinkedIn
url: https://www.linkedin.com/company/atsenatx
- type: Investors
url: https://atsenatx.com/about/investors/
- type: Partners
url: https://atsenatx.com/about/partners/
- type: SecondaryMarket
url: https://forgeglobal.com/atsena-therapeutics_stock/
- type: OpenAPI
url: openapi/_original/atsena-therapeutics-wp-rest-openapi.yml
- type: Overlay
url: overlays/atsena-therapeutics-wp-rest-overlay.yaml
- type: Authentication
url: authentication/atsena-therapeutics-authentication.yml
- type: Conventions
url: conventions/atsena-therapeutics-conventions.yml
- type: ErrorCatalog
url: errors/atsena-therapeutics-problem-types.yml
- type: DataModel
url: data-model/atsena-therapeutics-data-model.yml
- type: Lifecycle
url: lifecycle/atsena-therapeutics-lifecycle.yml
- type: Conformance
url: conformance/atsena-therapeutics-conformance.yml
- type: WellKnown
url: well-known/atsena-therapeutics-well-known.yml
- type: DomainSecurity
url: security/atsena-therapeutics-domain-security.yml
- type: LLMsTxt
url: llms/atsena-therapeutics-llms.txt
- type: AgentSkill
url: skills/_index.yml
x-enrichment-notes: 'Deliberately absent, each a verified negative probed on 2026-08-02, recorded so a later pass does not
re-litigate them: Idempotency (no idempotency contract exists on this surface — WordPress core implements no idempotency
key, and every modelled operation is a safe GET); SDKs and Packages (nothing first-party on npm, PyPI or any registry, and
no GitHub organization attributable to the company); StatusPage and Deprecation (status.atsenatx.com NXDOMAIN, no policy,
no RFC 8594 Sunset or Deprecation headers on any response); Security and SecurityTxt (/.well-known/security.txt 404, no
disclosure page, no bug bounty — probe-security-programs.py returned vdp=none); TrustCenter and Compliance (trust.atsenatx.com
NXDOMAIN, and the company''s own 29-page list contains no compliance, certification or state-disclosure document); AgentCard
(/.well-known/agent-card.json and /.well-known/agent.json both 404, against a host that serves a real HTML 404 rather than
an SPA catch-all 200, so this is a true negative); MCPServer and ToolCrosswalk (no mcp namespace among the 12 registered,
/.well-known/mcp.json 404 — note the wp-abilities/v1 registry IS installed but returns 401 anonymously, so no tool list
is readable); AsyncAPI and Webhooks (no event, streaming or webhook surface of any kind); OAuthScopes (no OAuth — /.well-known/oauth-authorization-server
and /.well-known/oauth-protected-resource both 404, so there is no scope surface to record); ContentSignal (robots.txt is
a bare Yoast block allowing everything, with no Content Signals Policy, no AI-preference directives and no named AI-crawler
rules — captured verbatim as evidence in well-known/ but not claimed as a signal); ChangeLog (no dated API changelog; the
newsroom is a press-release feed, not release notes); RateLimits (no limit published and no rate-limit headers observed);
TermsOfService (no terms page exists on the site); and Postman, Pricing, SignUp, Login, Roadmap, Documentation, DeveloperPortal,
APIReference, GettingStarted, CLI, Sandbox, Components and GitHubOrganization, none of which the company publishes. The
Support pointer is the general corporate contact form — there is no developer support channel.'
x-enrichment:
date: '2026-08-02'
status: enriched
artifacts_added: 16
pass: local-v1
Kin Score
How this is scored →